This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Lip
CD2_BENIGN_LIP_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum labii (oris)
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Lip
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Lip
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 776 | 391 | 385 |
| Unadjusted period prevalence (%) | 0.15 | 0.13 | 0.17 |
| Median age at first event (years) | 59.23 | 55.57 | 62.95 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 710
- Matched controls
- 7101
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.09
ICD-10 Finland
Benign tumor of the lip UNS
+∞
271.9
243
*
EAA10
NOMESCO Finland
Excision of lesion of lip
215.1
213.4
212
14
D10.04
ICD-10 Finland
Lower lip tumor in the lower lip mucosa
+∞
196.2
179
*
D10.00
ICD-10 Finland
Upper lip tumor in upper lip on lip lip border
+∞
114.8
107
*
TEA00
NOMESCO Finland
Biopsy of lip
56.2
67.9
80
16
D10.01
ICD-10 Finland
Uper lip tumor in the upper lip mucosa
+∞
64.6
61
*
D10.03
ICD-10 Finland
Lower lip tumor in the lower lip at the lip red border
+∞
52.8
50
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
522.8
50.0
49
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
46.4
44
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.4
45.2
97
117
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
42.1
40
*
130
Kela drug reimbursment
Malignant tumour
+∞
41.0
39
*
D10.0
ICD-10 Finland
Benign neoplasm: Lip
+∞
38.9
37
*
115
Kela drug reimbursment
Breast cancer
+∞
35.7
34
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
100.2
35.1
38
*
21000
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Lip
+∞
34.7
33
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
33.6
32
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
32.5
31
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
30.4
29
*
2100A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Lip
+∞
28.3
27
*
116
Kela drug reimbursment
Prostate cancer
+∞
27.3
26
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
25.1
24
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
15.1
24.2
40
28
C00.1
ICD-10 Finland
Malignant neoplasm: External lower lip
+∞
24.1
23
*
H02AB02
ATC
dexamethasone; systemic
15.5
22.7
37
25
A04AA02
ATC
granisetron; systemic, transdermal
+∞
22.0
21
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
22.0
21
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
226.6
21.7
22
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.8
18
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
18.8
18
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
18.8
18
*
HAC20
NOMESCO Finland
Total mastectomy
194.9
18.6
19
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
54.0
18.0
21
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
17.8
17
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
17.3
110
414
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
11.1
16.6
31
29
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
173.9
16.6
17
*
L57.0
ICD-10 Finland
Actinic keratosis
3.5
15.9
76
232
4381
FHL
Exemption of local change
61.4
15.8
18
*
L02AE02
ATC
leuprorelin; implant, parenteral
34.2
15.8
20
6
D10.05
ICD-10 Finland
Lower lip tumor in lower lip mucosa and on lip lip border
+∞
15.7
15
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.7
15
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
14.6
14
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
14.6
202
1134
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
153.0
14.5
15
*
L02BG04
ATC
letrozole; oral
11.7
14.4
26
23
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
13.8
51
125
ZX090
NOMESCO Finland
Other technic of radiotherapy
76.6
13.6
15
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
13.6
13
*
TQW99
NOMESCO Finland
Other minor procedure on skin
4.7
12.1
41
92
WF002
NOMESCO Finland
Radical radiotherapy
47.5
11.9
14
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
47.5
11.9
14
*
JN4BD
NOMESCO Finland
Extensive body CT
3.6
11.7
53
156
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
19.3
11.6
17
9
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
11.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
Y77
ICPC
Malignant neoplasm prostate
+∞
11.5
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
11.5
11
*
L02BB03
ATC
bicalutamide; oral
121.9
11.5
12
*
JN4AD
NOMESCO Finland
Body CT examination
5.1
11.3
35
72
D18.0
ICD-10 Finland
Haemangioma, any site
5.9
11.0
30
53
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.4
10.7
31
59
SPAT1153
SPAT
Removal of sutures
1.8
10.7
219
1395
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
6.7
10.6
26
40
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
111.6
10.4
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.4
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.4
10
*
C00.9
ICD-10 Finland
Malignant neoplasm: Lip, unspecified
+∞
10.4
10
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
10.4
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
10.4
287
2006
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
10.1
127
675
HA1AA
NOMESCO Finland
X-ray mammography
4.6
10.1
34
77
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
10.0
128
682
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.6
9.8
33
75
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.5
9.8
44
130
S18
ICPC
Laceration/cut
1.7
9.6
276
1938
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
Z51.5
ICD-10 Finland
Palliative care
5.2
9.3
28
56
A02BC02
ATC
pantoprazole; systemic
1.6
9.0
417
3314
L02BA01
ATC
tamoxifen; oral
37.2
9.0
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
8.7
273
1950
XX3DW
NOMESCO Finland
Time consuming IT work
3.4
8.6
40
122
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.2
8.5
25
49
D23.0
ICD-10 Finland
Benign neoplasm: Skin of lip
20.3
8.5
12
6
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.0
8.4
32
82
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
91.1
8.4
9
*
L03AA13
ATC
pegfilgrastim; parenteral
91.1
8.4
9
*
X76
ICPC
Malignant neoplasm breast female
+∞
8.3
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.3
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
L02BG03
ATC
anastrozole; oral
+∞
8.3
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.3
8
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.6
8.3
23
42
K11.69
ICD-10 Finland
Mukocele UNS
14.7
8.2
13
9
WZC30
NOMESCO Finland
Teaching
2.4
8.2
73
329
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.6
7.9
26
58
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
7.9
42
142
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.1
7.8
95
497
J01DB01
ATC
cefalexin; oral
1.6
7.6
541
4688
R01AD09
ATC
mometasone; nasal
1.6
7.6
278
2048
D83
ICPC
Mouth/tongue/lip disease
12.0
7.6
13
11
SXA10
NOMESCO Finland
Epithel biopsy of mouth
7.2
7.5
17
24
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
80.9
7.4
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
80.9
7.4
8
*
K13.78
ICD-10 Finland
Other change in the oral mucosa
5.7
7.4
20
36
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
7.3
57
243
N05CF01
ATC
zopiclone; oral
1.6
7.2
217
1518
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
7.2
157
1006
K13.03
ICD-10 Finland
Keilit UNS
20.2
7.1
10
5
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.9
6.9
18
31
D06BB10
ATC
imiquimod; topical
3.4
6.9
31
93
K13.09
ICD-10 Finland
Disease of the lips UNS
40.4
6.8
8
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
6.7
36
123
UKC02
NOMESCO Finland
Cystoscopy
1.9
6.7
102
577
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
22.7
6.7
9
*
K11.6
ICD-10 Finland
Mucocele of salivary gland
22.7
6.7
9
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.6
88
477
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
6.6
395
3228
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
6.5
37
131
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
70.4
6.4
7
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
6.4
192
1337
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.5
6.4
21
48
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.6
6.3
17
31
EKB00
NOMESCO Finland
Excision of lesion of cheek
11.1
6.3
11
10
H02AB07
ATC
prednisone; oral
1.9
6.3
99
571
C00.0
ICD-10 Finland
Malignant neoplasm: External upper lip
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
26.9
6.2
8
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
26.9
6.2
8
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
26.9
6.2
8
*
EKA10
NOMESCO Finland
Biopsy of cheek
4.0
6.2
23
59
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.4
6.2
51
225
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
6.1
66
329
N02AA05
ATC
oxycodone; systemic
2.0
6.0
80
430
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.0
176
1211
ZXC50
NOMESCO Finland
Cryotherapy
4.6
6.0
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
384
1874
3.08
51.54
2.5
1.7
—
—
—
0
0
(4035726)
84
164
5.62
41.78
1.4
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
91
291
3.41
23.51
2.6
1.5
ug/l
4.4
3.8
0.15
67
220
(3002256) Pathology report gross observation
111
456
2.67
18.31
1.3
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
366
2597
1.77
13.54
5.2
4.9
mmol/l
1.2
1.2
0.14
305
2289
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
557
4476
1.87
13.44
7.9
5.3
u/l
79.4
75.6
0.89
518
4126
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
391
2849
1.75
13.01
5.9
5.3
mmol/l
1.2
1.2
0.02
323
2414
(3013650) Neutrophils [#/volume] in Blood by Automated count
421
3167
1.72
12.20
8.8
6.4
e9/l
3.9
4.3
3.73
365
2762
(42870588) Differential panel, method unspecified - Blood
277
1862
1.76
11.99
5.8
5.4
—
—
—
0
0
(3019225) pH of Specimen
117
594
2.14
11.80
4.0
3.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
515
4144
1.72
11.22
4.7
4.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
272
1872
1.70
10.53
3.0
2.0
mmol/l
2.4
2.4
0.32
220
1546
(3013115) Eosinophils [#/volume] in Blood
391
2960
1.65
10.45
5.8
5.5
e9/l
0.2
0.2
0.57
333
2602
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
106
548
2.08
10.15
3.6
2.8
u/l
219.0
237.6
1.16
94
508
(3044640) Blood type and Crossmatch panel - Blood
248
1680
1.70
10.10
2.6
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
141
809
1.91
10.04
4.5
4.8
%
35.5
32.6
1.90
79
532
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
376
2842
1.63
9.94
6.2
3.6
umol/l
11.9
11.5
0.16
350
2653
(3006504) Eosinophils/100 leukocytes in Blood
354
2639
1.63
9.88
5.7
5.5
%
2.8
3.0
0.70
321
2438
(3022096) Basophils/100 leukocytes in Blood
345
2557
1.63
9.84
5.9
5.5
%
0.6
0.7
1.83
311
2368
(3002030) Lymphocytes/100 leukocytes in Blood
359
2701
1.61
9.54
6.0
5.6
%
27.7
27.5
0.13
321
2503
(3019069) Monocytes/100 leukocytes in Blood
353
2648
1.61
9.48
6.2
5.8
%
8.6
8.6
0.03
321
2463
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
200
1299
1.73
9.40
2.5
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
380
2911
1.60
9.28
5.7
5.4
e9/l
1.8
1.9
0.11
330
2558
(3001604) Monocytes [#/volume] in Blood
372
2840
1.60
9.19
5.6
5.3
e9/l
0.6
0.6
0.55
318
2461
(3006315) Basophils [#/volume] in Blood
373
2857
1.59
9.04
5.7
5.4
e9/l
0.0
0.0
3.50
322
2480
(3018010) Neutrophils/100 leukocytes in Blood
354
2683
1.59
8.94
5.6
5.4
%
57.5
57.6
0.03
321
2495
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
342
2573
1.59
8.90
4.0
3.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
53
218
2.54
8.66
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
34
5.09
8.17
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
35
120
3.01
8.06
3.1
1.9
u/ml
459.7
109.7
0.86
28
95
(3013826) Glucose [Moles/volume] in Serum or Plasma
438
3536
1.55
8.06
4.6
4.1
mmol/l
6.9
6.8
0.21
409
3288
(40768793) Breast Pathology biopsy report
20
49
4.16
7.57
1.6
1.1
—
—
—
0
0
(3013512) EKG study
254
1847
1.56
7.33
4.3
3.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
213
1503
1.57
6.95
3.8
3.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
316
2433
1.50
6.90
4.7
3.6
g/l
35.5
35.6
0.13
286
2241
(3032080) INR in Blood by Coagulation assay
310
2378
1.51
6.89
8.3
9.7
inr
1.2
1.3
0.79
61
695
(3013707) Erythrocyte sedimentation rate by Westergren method
527
4515
1.52
6.74
4.9
4.1
mm/h
12.9
11.9
0.84
464
4121
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
52
239
2.26
6.69
1.8
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
80
3.20
6.49
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
128
812
1.69
6.37
8.2
6.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
423
3494
1.46
6.28
2.7
2.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
14
30
4.73
6.23
2.6
1.3
ug/l
13.9
14.7
0.13
14
30
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
99
591
1.77
6.11
2.7
2.3
umol/l
7.7
7.5
0.04
88
518
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
143
952
1.62
5.88
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
609
5451
1.54
5.75
18.2
13.5
%
39.8
40.1
0.37
388
3720
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
18
51
3.59
5.63
1.6
1.4
u/l
13.9
28.9
1.16
11
35
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
66
3.24
5.63
1.7
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
659
6018
1.63
5.58
17.1
12.4
mg/l
22.7
23.1
0.13
543
4663
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
224
2.17
5.57
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
67
3.19
5.50
1.7
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
67
3.19
5.50
1.7
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
328
2629
1.43
5.46
2.2
2.0
pmol/l
94.7
95.3
0.08
158
1350
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
68
3.15
5.37
1.7
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
68
3.15
5.37
1.7
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
68
3.15
5.37
1.7
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
129
862
1.60
5.20
24.8
25.7
inr
1.3
1.4
0.10
18
120
(3033658) Prothrombin time (PT) actual/Normal
188
1368
1.49
5.15
4.0
3.3
%
91.9
88.1
1.19
179
1328
(3017732) Neutrophils [#/volume] in Blood
69
394
1.82
4.95
3.0
2.6
e9/l
3.9
4.1
0.31
36
290
(3035320) C reactive protein [Mass/volume] in Body fluid
13
33
3.99
4.72
3.3
2.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
448
3851
1.39
4.71
3.2
3.0
u/l
47.7
45.9
0.19
405
3563
(40758558) Short blood count panel - Blood
180
1324
1.47
4.63
5.5
4.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
202
1521
1.44
4.59
2.4
2.2
mg/l
2.9
3.0
0.19
156
1265
(3018418) pH of Serum or Plasma
216
1658
1.42
4.39
3.3
3.1
ph
7.4
7.4
0.22
28
268
(3022313) Gas panel - Capillary blood
52
286
1.88
4.22
3.5
3.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
260
2073
1.38
4.21
3.5
3.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
72
439
1.71
4.15
3.6
1.6
g/l
66.5
67.5
0.45
56
392
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
235
1851
1.39
4.07
2.6
2.2
u/l
60.2
57.4
0.51
210
1689
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
726
1.55
4.02
2.5
2.4
%
22.6
23.8
0.40
86
619
(3004789) Transferrin [Mass/volume] in Serum or Plasma
115
795
1.52
3.97
2.4
2.3
g/l
2.3
2.3
0.07
102
732
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
614
5642
1.42
3.86
5.5
4.6
mu/l
1.9
2.2
0.62
535
5125
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
299
2464
1.35
3.85
2.4
2.3
nmol/l
77.3
77.9
0.13
245
2158
(40768797) Stomach Pathology biopsy report
116
811
1.51
3.80
1.1
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
116
819
1.49
3.63
3.8
2.4
mmol/l
0.8
0.8
0.17
103
757
(3026008) Bacteria identified in Urine by Culture
225
1792
1.36
3.57
3.4
3.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
676
6350
1.50
3.54
19.7
14.7
mmol/l
139.7
139.8
0.49
652
6170
(3023103) Potassium [Moles/volume] in Serum or Plasma
678
6373
1.51
3.54
19.8
14.8
mmol/l
4.0
4.0
1.75
651
6184
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
76
491
1.61
3.53
3.5
2.1
u/l
36.0
32.6
0.33
58
400
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
10
26
3.88
3.53
6.6
2.1
nmol/l
2.9
3.7
—
10
26
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
82
544
1.57
3.42
3.0
3.0
ng/l
122.6
223.8
4.18
71
506
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
618
5724
1.39
3.38
15.7
11.2
ml/min/173m2
78.4
79.0
0.26
513
4598
(3022145) Colonoscopy Study observation
86
579
1.55
3.36
1.4
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
48
2.95
3.31
2.6
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
43
242
1.82
3.30
1.4
1.6
g/l
1.4
1.5
0.41
35
209
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
122
2.17
3.29
1.8
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
61
382
1.65
3.22
2.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
62
390
1.64
3.22
2.7
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
130
960
1.43
3.22
2.9
2.6
e6/l
1.4
1.1
0.30
67
547
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
201
1.88
3.17
2.5
1.4
g/l
11.6
11.0
0.20
24
168
(3004809) Band form neutrophils/100 leukocytes in Blood
15
55
2.76
3.17
2.6
2.8
%
2.5
1.0
—
8
42
(3019309) Folate [Moles/volume] in Red Blood Cells
160
1229
1.38
3.15
1.9
1.7
nmol/l
1086.8
1165.8
0.42
100
921
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
35
187
1.91
3.15
3.5
1.5
u/ml
14.5
23.4
1.01
35
179
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
43
246
1.79
3.14
3.5
3.9
mmol/l
25.0
24.9
0.07
35
227
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
688
6519
1.49
3.10
12.1
8.8
u/l
27.8
26.1
0.68
657
6235
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
145
1099
1.39
3.09
2.7
2.1
mmol/l
2.5
2.4
1.40
128
938
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
218
1.83
3.07
3.4
1.4
g/l
7.7
7.6
0.14
22
159
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
218
1.83
3.07
3.4
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
218
1.83
3.07
3.4
1.4
g/l
3.9
3.9
0.07
21
155
(3014271) Vancomycin [Susceptibility]
11
34
3.27
3.06
3.5
2.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
111
809
1.43
2.96
2.2
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
196
1572
1.33
2.91
3.5
2.8
e6/l
0.3
0.4
0.31
142
1192
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
61
393
1.60
2.90
3.9
3.5
kpa
4.9
5.2
1.54
54
368
(3021960) Folate [Moles/volume] in Serum or Plasma
193
1549
1.33
2.85
1.7
1.5
nmol/l
21.6
20.5
0.36
149
1315
(3003458) Phosphate [Moles/volume] in Serum or Plasma
103
746
1.44
2.84
4.7
4.5
mmol/l
1.0
1.0
1.11
86
670
(3018095) Leukocytes [#/volume] in Urine
245
2033
1.30
2.84
4.0
3.5
e6/l
55.2
118.1
1.41
166
1441
(3024731) MCV [Entitic volume]
710
6791
1.53
2.84
25.3
18.1
fl
91.1
91.2
0.19
695
6662
(3001122) Ferritin [Mass/volume] in Serum or Plasma
296
2518
1.28
2.83
3.1
2.7
ug/l
144.1
116.9
0.54
258
2291
(3026361) Erythrocytes [#/volume] in Blood
710
6793
1.53
2.81
25.4
18.2
e12/l
4.5
4.5
0.97
686
6561
(3010813) Leukocytes [#/volume] in Blood
710
6794
1.53
2.79
25.4
18.2
e9/l
6.9
6.7
0.34
686
6564
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
121
905
1.40
2.79
3.0
2.8
e6/l
3.4
2.1
0.79
59
492
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
646
6078
1.38
2.79
5.1
4.7
mmol/l
6.0
6.0
0.16
558
5507
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
56
357
1.61
2.79
1.8
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
710
6795
1.53
2.78
25.5
18.3
g/l
134.5
136.2
2.24
695
6667
(4010399)
67
447
1.55
2.76
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
6
8.38
2.75
1.8
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
235
1947
1.30
2.74
2.3
2.1
u/l
179.3
245.9
0.82
213
1825
(3023520) Reticulocytes [#/volume] in Blood
73
498
1.51
2.72
4.5
2.2
e9/l
75.0
68.1
0.93
56
389
(3007853) Bacteria identified in Skin by Aerobe culture
91
650
1.45
2.70
2.1
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
205
1.79
2.70
3.1
1.4
g/l
3.0
3.1
0.12
21
156
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
258
2168
1.28
2.69
5.5
3.8
ug/l
4.1
2.0
0.74
220
1928
(3035941) MCH [Entitic mass]
709
6792
1.51
2.67
25.3
18.1
pg
30.3
30.4
0.44
695
6662
(36304419) Bacteria [Presence] in Urine
189
1526
1.32
2.66
3.5
2.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
32
3.15
2.65
1.8
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
118
891
1.38
2.58
2.5
2.2
umol/l
13.0
13.5
0.33
103
806
(3049717) Cytology report of Urine Cyto stain
32
179
1.82
2.55
3.2
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
79
556
1.47
2.54
3.5
3.1
mmol/l
2.3
1.9
0.51
63
448
(3007164) IgA [Mass/volume] in Serum or Plasma
141
1098
1.35
2.54
1.5
1.3
g/l
2.4
2.6
0.35
78
652
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
626
5885
1.33
2.53
4.3
4.1
mmol/l
1.3
1.3
0.28
537
5345
(40761511) CBC panel - Blood by Automated count
668
6343
1.38
2.51
16.4
12.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
82
2.22
2.49
1.9
1.4
%
41.1
63.9
1.45
13
51
(3000991) Gas panel - Venous blood
67
458
1.51
2.49
6.3
6.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
209
1726
1.29
2.47
3.6
3.0
e6/l
63.2
96.9
0.34
158
1338
(1761868) Lipid panel - Serum or Plasma
173
2114
0.77
2.46
3.1
3.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
17
76
2.26
2.45
1.5
2.9
—
23.8
—
0
17
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
506
4639
1.26
2.44
4.4
3.8
pmol/l
14.9
14.8
0.05
424
4196
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
228
1908
1.28
2.42
3.1
2.9
ng/l
1420.2
1485.8
0.11
189
1601
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
661
6275
1.36
2.41
5.4
5.1
mmol/l
2.7
2.7
0.30
575
5748
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
175
1.80
2.41
1.6
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
707
6789
1.47
2.40
25.4
18.2
e9/l
248.4
247.6
0.12
688
6587
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
161
1290
1.31
2.38
1.2
1.2
u/ml
2.4
1.7
0.21
31
350
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
276
1.63
2.37
6.4
9.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
22
3.66
2.37
2.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
22
3.66
2.37
2.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
74
523
1.46
2.34
1.5
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
177
1.78
2.33
1.8
1.3
g/l
36.9
37.8
0.26
17
146
(3017446) Testosterone [Moles/volume] in Serum or Plasma
56
374
1.54
2.32
3.1
2.2
nmol/l
11.3
14.8
1.89
46
328
(3000494) Fungus identified in Specimen by Culture
95
708
1.39
2.26
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
18
3.91
2.25
2.1
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
18
3.91
2.25
2.1
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
215
1803
1.27
2.23
3.5
2.6
u/l
29.9
34.7
1.65
203
1713
(3015736) pH of Urine
270
2327
1.25
2.20
2.9
3.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
48
2.52
2.19
2.7
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
648
6155
1.32
2.18
4.9
4.6
mmol/l
4.6
4.6
0.45
570
5662
(36660697) Celiac disease serology panel - Serum
66
463
1.47
2.18
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
150
1205
1.30
2.17
2.8
2.3
e6/l
3.9
6.5
2.18
131
1048
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
55
372
1.51
2.17
3.9
3.4
mmol/l
1.5
1.9
0.29
40
278
(3000492) Spirometry study
76
549
1.43
2.16
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
48
316
1.55
2.14
1.3
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
281
2439
1.24
2.14
4.2
3.7
ng/l
43.0
59.0
0.40
207
1717
(3010144) Erythrocytes [#/volume] in Synovial fluid
13
55
2.39
2.13
1.5
1.3
e6/l
4224.3
309153.0
—
8
39
(3035350) Ketones [Presence] in Urine by Test strip
331
2925
1.23
2.13
3.2
3.6
estimate
0.0
0.0
0.00
40
498
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
102
1.99
2.12
2.0
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
80
586
1.41
2.11
2.7
2.5
ug/l
5.8
7.1
0.37
63
505
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
642
6099
1.30
2.09
5.0
4.6
mmol/l
1.4
1.5
0.38
561
5585
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
176
1.73
2.09
2.4
3.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
334
2959
1.23
2.08
3.3
3.6
estimate
0.0
0.0
0.80
40
487
(3045414) Leukocytes [Presence] in Urine
39
246
1.62
2.08
2.1
1.9
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
10
5.02
2.07
5.4
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
330
2922
1.23
2.06
4.6
4.9
estimate
0.0
0.0
0.00
43
498
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
89
667
1.38
2.06
1.8
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
153
1244
1.29
2.02
1.7
1.6
mg/l
1.1
1.1
0.07
113
936
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54
371
1.49
2.00
1.9
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
41
265
1.58
1.99
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
48
323
1.52
1.96
2.6
3.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
135
1.80
1.93
2.5
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
611
5788
1.26
1.91
6.4
6.1
mmol/mol
40.3
40.2
0.05
535
5342
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
27
160
1.71
1.84
1.4
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
72
532
1.39
1.83
2.9
1.8
nmol/l
360.6
366.5
0.09
65
483
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
12
4.19
1.82
2.6
3.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
26
153
1.72
1.81
1.6
1.4
ug/g
254.9
313.0
0.76
15
89
(3014599) Egg white IgE Ab [Units/volume] in Serum
8
29
2.78
1.79
1.0
1.0
—
0.3
—
0
6
(3037756) Immunofixation for Serum or Plasma
18
95
1.92
1.76
1.8
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
65
479
1.39
1.69
3.5
2.2
ml/min/173m2
71.1
68.5
0.21
32
208
(3021387) Prolactin [Units/volume] in Serum or Plasma
24
142
1.71
1.66
1.7
1.6
mu/l
339.7
291.8
0.29
24
127
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
29
181
1.63
1.65
3.0
1.4
g/l
2.8
0.4
0.87
19
156
(3027945) Reticulocytes/100 erythrocytes in Blood
88
685
1.32
1.62
3.1
2.1
%
2.1
1.8
1.95
70
602
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
46
321
1.46
1.61
2.4
2.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
160
1348
1.24
1.57
1.9
1.7
pmol/l
430.9
9763202.4
0.80
116
1096
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
142
1182
1.25
1.55
5.4
3.9
ng/l
61.6
363.0
4.69
112
937
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
71
1.99
1.54
1.6
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
85
665
1.31
1.52
5.4
6.3
mmol/l
1.4
1.3
0.05
65
513
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
27
2.61
1.51
1.1
2.5
—
—
—
0
0
(3026782) Osmolality of Urine
137
1140
1.25
1.51
2.8
2.4
mosm/kgh2o
538.4
550.1
0.26
110
951
(4306422)
13
65
2.02
1.49
1.2
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
25
155
1.63
1.48
1.8
1.6
e6/l
7178.4
13846.1
0.81
18
118
(3012501) Base excess in Blood by calculation
19
109
1.76
1.48
5.1
3.5
mmol/l
1.5
3.0
—
10
74
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
28
2.51
1.45
5.4
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
99
797
1.28
1.44
1.7
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
16
3.14
1.44
2.6
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
16
3.14
1.44
2.6
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
16
3.14
1.44
2.6
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
19
110
1.75
1.44
5.1
3.6
kpa
8.2
8.3
0.09
19
110
(3013290) Carbon dioxide [Partial pressure] in Blood
19
110
1.75
1.44
5.1
3.6
kpa
4.9
5.1
0.37
19
110
(3003129) Base excess in Capillary blood by calculation
6
22
2.74
1.43
2.5
1.2
mmol/l
0.6
1.3
—
6
22
(44813793)
9
39
2.32
1.43
1.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
41
289
1.44
1.39
1.4
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
184
1592
1.20
1.39
2.8
2.4
umol/l
6553.4
6620.4
0.01
148
1363
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
158
1.60
1.39
1.5
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
67
1.96
1.39
1.8
2.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
84
666
1.29
1.38
5.5
6.3
kpa
5.1
5.1
0.14
77
635
(3027801) Oxygen [Partial pressure] in Arterial blood
84
666
1.29
1.38
5.5
6.2
kpa
12.4
11.7
0.68
77
635
(4133840)
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
85
677
1.29
1.35
2.6
2.2
ug/g
97.5
133.0
1.01
59
521
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
98
1.75
1.32
1.2
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
20
121
1.67
1.32
2.4
1.9
pmol/l
187.9
231.0
0.88
20
114
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
43
2.11
1.30
2.7
3.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
67
521
1.31
1.28
2.7
3.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
62
1.95
1.28
1.1
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
83
666
1.28
1.26
1.9
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
70
1.87
1.24
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
161
1391
1.20
1.24
3.3
3.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
19
2.64
1.21
1.8
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
124
1.63
1.21
1.8
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
97
798
1.25
1.20
1.4
1.3
titre
946.7
584.7
0.52
21
180
(3027273) Bicarbonate [Moles/volume] in Venous blood
42
308
1.38
1.18
2.5
2.9
mmol/l
25.7
25.2
0.41
42
298
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
404
1.33
1.17
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
26
174
1.51
1.16
1.8
2.0
s
21.2
21.1
0.02
20
154
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
3.2
—
1242.3
—
0
33
(3035880) pH of Pleural fluid
5
20
2.51
1.15
1.0
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
12
65
1.86
1.14
1.0
1.1
%
138.4
117.4
—
7
60
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
111
1.64
1.13
1.7
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
58
1.91
1.12
1.8
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
51
1.97
1.11
1.9
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
57
444
1.31
1.10
2.1
1.9
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
74
1.77
1.07
1.1
1.1
—
12.1
—
0
6
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
129
1.56
1.06
1.2
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
33
237
1.41
1.06
1.8
2.1
u/l
40.8
39.1
0.21
26
206
(4268621)
9
46
1.97
1.04
2.2
2.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
2.6
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
2.6
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
2.6
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
2.6
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
130
1.55
1.03
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
83
1.70
1.02
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
78
640
1.24
1.01
1.6
1.5
—
—
—
0
0
(4024509)
9
48
1.88
1.00
1.3
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
30
216
1.40
0.97
2.0
1.7
ug/l
0.9
1.4
0.58
22
189
(3045716) Anion gap in Serum or Plasma
0
31
0.00
0.96
0.0
1.5
—
9.4
—
0
26
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
85
1.66
0.94
1.9
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
51
1.77
0.94
4.4
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
134
1.51
0.92
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
10
55
1.83
0.92
1.8
1.3
%
39.6
30.1
—
5
33
(40768441) Liver Pathology biopsy report
6
28
2.15
0.91
1.3
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
29
2.08
0.89
1.2
1.1
ug/l
2.3
3.8
—
6
24
(3000012) Reticulocyte production index
6
29
2.08
0.89
2.0
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
42
1.91
0.88
1.5
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
16
103
1.57
0.88
3.4
1.9
%
69.5
62.6
0.84
16
103
(40760892) CBC W Ordered Manual Differential panel - Blood
141
1243
1.16
0.87
4.9
4.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
88
1.60
0.84
1.3
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
6
31
1.94
0.84
1.0
1.0
—
0.3
—
0
10
(3025130) Human papilloma virus identified in Specimen
8
45
1.79
0.84
1.4
1.7
—
—
—
0
0
(4034850)
16
238
0.67
0.84
10.9
9.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
137
0.58
0.84
1.5
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
14
89
1.58
0.81
1.0
1.2
nmol/l
0.6
0.6
0.05
14
82
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.1
—
71.2
—
0
6
(3051593) INR in Capillary blood by Coagulation assay
6
33
1.82
0.79
11.2
9.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
115
1.49
0.77
1.7
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
469
1.23
0.76
3.3
3.6
ng/l
76.9
88.1
0.76
45
411
(3009508) Creatinine [Moles/volume] in Urine
224
2059
1.12
0.76
3.0
3.1
mmol/l
7.3
7.6
0.30
171
1712
(3026389) Candida sp identified in Specimen by Organism specific culture
11
67
1.65
0.75
1.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
51
415
1.25
0.75
3.4
4.1
%
1.1
0.8
0.47
16
88
(4015189)
5
24
2.09
0.74
5.2
2.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
47
380
1.25
0.73
3.1
4.1
%
0.6
0.5
—
9
68
(4146454)
13
84
1.56
0.72
1.7
2.9
—
—
—
0
0
(44790048)
9
57
1.59
0.71
1.4
1.4
—
—
—
0
0
(44790047)
9
57
1.59
0.71
1.4
1.4
—
—
—
0
0
(44790049)
9
57
1.59
0.71
1.4
1.4
—
—
—
0
0
(44806118)
9
57
1.59
0.71
1.4
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
26
1.93
0.70
2.4
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
110
1.46
0.68
3.4
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
503
1.21
0.68
2.1
2.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.86
0.68
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
161
1461
1.13
0.68
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
104
918
1.15
0.66
1.4
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
2.6
3.0
umol/l
28.6
30.3
—
5
21
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
29
1.73
0.64
2.0
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
48
398
1.22
0.62
3.4
4.2
%
0.1
0.0
0.31
15
78
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
20
147
1.37
0.62
1.8
1.3
g/l
0.0
0.0
0.00
15
137
(3000093) Morphology [Interpretation] in Blood Narrative
8
49
1.64
0.62
1.3
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
233
0.72
0.61
1.5
1.9
mg/l
3.1
3.3
—
8
174
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
51
1.57
0.60
1.9
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
52
1.54
0.59
2.5
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
72
1.54
0.59
1.5
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
106
1.42
0.58
2.7
2.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
36
1.67
0.56
1.0
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
20
150
1.34
0.56
1.8
1.3
g/l
0.0
0.0
0.00
15
138
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
90
1.45
0.55
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
37
1.63
0.55
1.3
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
168
1.32
0.55
3.0
3.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
38
1.58
0.54
1.5
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
21
160
1.32
0.54
3.0
1.3
g/l
0.0
0.0
0.50
16
148
(1761482) Bacteria [#/volume] in Urine by Culture
22
169
1.31
0.53
2.2
4.5
—
—
—
0
0
(3010421) pH of Blood
19
143
1.34
0.53
5.1
3.3
ph
7.4
7.4
0.29
19
109
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
100
0.60
0.52
1.3
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
25
197
1.28
0.51
2.2
2.4
g/l
0.6
0.3
—
10
64
(3012516) Albumin [Mass/volume] in Urine
210
1965
1.09
0.51
3.2
3.2
mg/l
289.7
250.3
0.06
135
1222
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
35
289
1.22
0.49
3.0
3.3
%
52.2
48.3
0.38
35
284
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
2.4
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
46
1.53
0.48
1.7
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
2.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
2.4
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
186
1737
1.09
0.47
4.8
3.7
%
22.1
24.5
1.16
75
790
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
300
1.21
0.47
4.8
3.1
pmol/l
4.5
4.6
0.28
28
260
(3011648) Oxygen content in Venous blood
7
48
1.46
0.47
2.9
1.4
%
13.0
10.8
—
7
48
(3044941) Cell count panel - Synovial fluid
14
103
1.37
0.45
1.3
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
22
174
1.27
0.45
1.5
1.2
u/ml
2.6
6.4
—
5
29
(3051611) Lipemic interference index of Serum or Plasma
7
50
1.40
0.45
1.6
2.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
31
1.62
0.43
1.6
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
203
1.24
0.42
1.8
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
206
0.77
0.42
1.5
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
7.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
34
1.47
0.40
3.0
2.1
umol/l
40.0
56.7
—
5
26
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
169
1.25
0.39
2.0
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
80
1.38
0.38
1.3
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
134
1.27
0.37
3.1
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
85
777
1.11
0.35
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
330
0.84
0.35
1.7
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
6
43
1.40
0.35
2.7
1.8
—
1.7
—
0
5
(3012441) Differential panel - Pleural fluid
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
82
1.35
0.34
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
218
2080
1.07
0.33
3.8
4.0
mg/mmol
18.9
8.7
0.52
130
1297
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
6
46
1.31
0.33
1.2
1.1
—
2.6
—
0
8
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
47
1.28
0.32
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
110
1.28
0.32
6.9
2.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
52
1.35
0.31
1.1
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
54
1.30
0.30
1.1
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
139
1.23
0.29
1.5
1.3
miu/ml
205.9
243.5
—
7
68
(3019060) Gas panel - Arterial blood
44
393
1.13
0.28
4.1
4.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
22
259
0.85
0.28
1.9
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
10
76
1.32
0.28
1.1
1.1
u/ml
0.7
1.2
—
5
30
(3019150) Specific gravity of Urine by Refractometry
146
1384
1.07
0.28
3.5
3.9
kg/l
1.0
1.0
0.56
30
195
(3027456) Digoxin [Moles/volume] in Serum or Plasma
17
140
1.22
0.27
3.8
3.2
nmol/l
0.8
0.8
0.19
12
110
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
120
0.75
0.27
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
113
1.24
0.26
1.1
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
113
1.24
0.26
1.1
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
71
656
1.09
0.26
1.5
1.8
%
1.4
1.5
1.25
54
571
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
75
0.66
0.26
1.4
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
73
1.24
0.25
1.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
73
1.24
0.25
1.7
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
38
340
1.12
0.25
1.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
454
0.90
0.24
1.5
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
212
0.85
0.24
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
161
1681
0.95
0.23
1.8
1.6
mmol/l
1.3
1.4
0.28
130
1406
(3029937) Albumin [Presence] in Urine by Test strip
150
1568
0.95
0.23
3.7
3.8
estimate
0.0
0.0
0.69
39
487
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
15
125
1.20
0.22
2.3
2.5
g/l
3.3
3.6
0.44
15
118
(3045142) Bone marrow Pathology biopsy report
5
40
1.25
0.22
2.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
135
0.81
0.22
3.0
4.0
mg/l
31.2
25.4
—
6
91
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
26.0
—
0
11
(3044007) Cell count panel - Peritoneal fluid
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
12
0.00
0.21
0.0
2.0
—
1.2
—
0
12
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
145
0.82
0.21
1.9
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
230
1.13
0.21
1.7
1.9
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
2.7
—
1677.5
—
0
6
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
145
1.18
0.20
1.1
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
469
0.91
0.20
1.8
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
48
1.25
0.20
1.2
1.5
—
22.4
—
0
9
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
14
0.00
0.20
0.0
7.9
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
16.4
—
0
14
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
25
222
1.13
0.19
1.6
1.6
—
121.8
—
0
11
(3003740) Influenza virus B Ag [Presence] in Specimen
10
81
1.24
0.19
1.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
249
2555
0.96
0.18
9.3
8.1
e9/l
0.0
0.0
0.26
202
2095
(3019832) Treponema pallidum Ab [Presence] in Serum
42
387
1.09
0.18
1.6
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
91
1.21
0.17
1.3
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
82
1.22
0.17
1.6
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
82
1.22
0.17
2.1
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
66
0.76
0.17
1.0
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
67
0.74
0.17
1.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
69
0.72
0.17
1.2
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
215
1.12
0.16
1.5
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
234
2281
1.04
0.16
3.5
3.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
92
1.20
0.16
1.5
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
606
0.94
0.16
3.0
2.9
—
—
—
0
0
(4094501)
15
172
0.87
0.16
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
78
1.16
0.15
1.0
1.3
nmol/l
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
9
79
1.14
0.15
1.1
1.2
—
108.0
—
0
13
(3023419) Bacteria identified in Sputum by Culture
9
80
1.13
0.15
3.0
2.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
46
430
1.07
0.15
3.6
2.5
mmol/l
1.2
1.2
0.74
40
354
(3011985) Renin [Units/volume] in Plasma
9
82
1.10
0.15
1.3
1.3
mu/l
11.1
51.5
—
9
74
(3002523) Influenza virus A Ag [Presence] in Specimen
9
82
1.10
0.15
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
45
481
0.93
0.14
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
44
470
0.93
0.14
3.7
3.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
274
0.91
0.14
1.8
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
97
0.82
0.13
1.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
159
0.88
0.13
1.5
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
106
0.85
0.13
1.6
2.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
162
1577
1.03
0.12
3.0
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
69
660
1.05
0.12
1.8
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
125
1214
1.04
0.11
3.3
2.7
ug/l
0.8
0.8
0.15
71
798
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
86
1.16
0.11
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
436
4323
1.02
0.08
4.2
3.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
60
0.83
0.08
1.2
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
65
0.77
0.08
2.2
3.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
23
246
0.93
0.08
1.1
1.1
—
97.3
—
0
7
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
45
431
1.05
0.08
2.8
2.4
—
21.6
—
0
16
(3005570) Glucose [Moles/volume] in Urine
6
71
0.84
0.07
1.8
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
137
1.10
0.07
1.3
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
75
1.07
0.07
1.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
81
0.86
0.07
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
85
1.06
0.07
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
89
1.13
0.07
1.3
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
89
1.13
0.07
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
105
1028
1.02
0.06
1.3
1.3
u/ml
6.3
12.0
0.56
35
400
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
100
0.90
0.06
4.6
3.5
%
54.0
58.7
—
9
100
(3002385) Erythrocyte distribution width [Ratio]
496
4932
1.02
0.06
20.4
14.8
%
13.7
13.6
0.96
490
4810
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
188
1.07
0.05
1.7
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
161
0.93
0.05
1.5
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
161
0.93
0.05
1.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
160
0.94
0.04
1.5
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
109
1076
1.02
0.03
1.3
1.3
iu/ml
18.1
33.8
3.05
34
337
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
122
1.07
0.02
1.5
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
166
1.02
0.00
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
166
1.02
0.00
1.4
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
166
1.02
0.00
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
117
1.03
0.00
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
117
1.03
0.00
1.7
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
39
385
1.01
0.00
3.5
4.3
%
0.0
1.2
—
10
71
(3020891) Body temperature
25
246
1.02
0.00
4.7
4.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
173
0.98
0.00
2.2
2.3
ug/min
51.9
86.1
—
9
106
(3016879) Cocaine [Presence] in Urine
15
148
1.01
0.00
1.5
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
139
1.01
0.00
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
151
0.99
0.00
2.9
2.5
u/ml
0.3
0.4
—
10
93
(42529406) Shigella sp [Presence] in Stool by Culture
17
169
1.01
0.00
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
25
249
1.00
0.00
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
38
381
1.00
0.00
1.2
1.2
iu/ml
180.5
114.4
—
8
159
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
83
0.96
0.00
1.6
1.6
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
16.8
—
0
5
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
99
0.91
0.00
4.2
3.1
e9/l
2.6
4.4
—
9
99
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
65.4
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
86
0.93
0.00
2.6
2.2
mmol/l
106.2
105.1
—
8
86
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
95
0.95
0.00
1.1
1.2
—
—
—
0
0
(4062490)
5
58
0.86
0.00
1.2
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
53
0.94
0.00
7.6
2.5
%
14.2
13.3
—
5
53
(3041354) Potassium [Moles/volume] in Venous blood
8
86
0.93
0.00
2.6
2.2
mmol/l
4.1
4.1
—
8
86
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
85
0.94
0.00
2.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
80
1.00
0.00
1.3
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
5.7
—
6.4
—
0
7
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
85
0.94
0.00
2.6
2.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
54
0.93
0.00
1.2
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LIP_EXALLC – Benign neoplasm: Lip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).